BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27803304)

  • 21. Ultrasound Evaluation of Three Outcome Domains in the Follow-up of Urate-Lowering Therapy in Gout: An Observational Study.
    Zhang W; Zhao D; Wu M; Chen W; Jin Z; Zhang H
    Ultrasound Med Biol; 2021 Jun; 47(6):1495-1505. PubMed ID: 33785225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Tophus Impact Questionnaire (TIQ-20): responsiveness to change during urate-lowering therapy.
    Cao C; Gamble G; Horne A; Aati O; Doyle A; Drake J; Stamp LK; Dalbeth N
    Rheumatology (Oxford); 2024 May; 63(6):1539-1542. PubMed ID: 37688559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a computed tomography method of scoring bone erosion in patients with gout: validation and clinical implications.
    Dalbeth N; Doyle A; Boyer L; Rome K; Survepalli D; Sanders A; Sheehan T; Lobo M; Gamble G; McQueen FM
    Rheumatology (Oxford); 2011 Feb; 50(2):410-6. PubMed ID: 21059673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gout of feet and ankles in different disease durations: diagnostic value of single-source DECT and evaluation of urate deposition with a novel semi-quantitative DECT scoring system.
    Shang J; Li XH; Lu SQ; Shang Y; Li LL; Liu B
    Adv Rheumatol; 2021 Jun; 61(1):36. PubMed ID: 34118994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual energy computed tomography: a novel technique for diagnosis of gout.
    Ahmad Z; Gupta AK; Sharma R; Bhalla AS; Kumar U; Sreenivas V
    Int J Rheum Dis; 2016 Sep; 19(9):887-96. PubMed ID: 27125882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Path Analysis Identifies Receptor Activator of Nuclear Factor-κB Ligand, Osteoprotegerin, and Sclerostin as Potential Mediators of the Tophus-bone Erosion Relationship in Gout.
    Chhana A; Aati O; Gamble GD; Callon KE; Doyle AJ; Roger M; McQueen FM; Horne A; Reid IR; Cornish J; Dalbeth N
    J Rheumatol; 2016 Feb; 43(2):445-9. PubMed ID: 26773114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual-Energy Computed Tomography of the Knee, Ankle, and Foot: Noninvasive Diagnosis of Gout and Quantification of Monosodium Urate in Tendons and Ligaments.
    Fritz J; Henes JC; Fuld MK; Fishman EK; Horger MS
    Semin Musculoskelet Radiol; 2016 Feb; 20(1):130-6. PubMed ID: 27077593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiologic evidence of symmetric and polyarticular monosodium urate crystal deposition in gout - A cluster pattern analysis of dual-energy CT.
    Yokose C; Dalbeth N; Wei J; Nicolaou S; Simeone FJ; Baumgartner S; Fung M; Zhang Y; Choi HK
    Semin Arthritis Rheum; 2020 Feb; 50(1):54-58. PubMed ID: 31371194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a Dual-Energy Computed Tomography Scoring System for Measurement of Urate Deposition in Gout.
    Bayat S; Aati O; Rech J; Sapsford M; Cavallaro A; Lell M; Araujo E; Petsch C; Stamp LK; Schett G; Manger B; Dalbeth N
    Arthritis Care Res (Hoboken); 2016 Jun; 68(6):769-75. PubMed ID: 26474153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of gout: New tools and biomarkers?
    Araujo EG; Manger B; Perez-Ruiz F; Thiele RG
    Best Pract Res Clin Rheumatol; 2016 Aug; 30(4):638-652. PubMed ID: 27931959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic staging for urate crystal deposits with dual-energy CT and ultrasound in patients with suspected gout.
    Huppertz A; Hermann KG; Diekhoff T; Wagner M; Hamm B; Schmidt WA
    Rheumatol Int; 2014 Jun; 34(6):763-71. PubMed ID: 24619560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound imaging for the rheumatologist XXXVI. Sonographic assessment of the foot in gout patients.
    Filippucci E; Meenagh G; Delle Sedie A; Sakellariou G; Iagnocco A; Riente L; Gutierrez M; Bombardieri S; Valesini G; Montecucco C; Grassi W
    Clin Exp Rheumatol; 2011; 29(6):901-5. PubMed ID: 22206648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of monosodium urate deposits in a population of rheumatoid arthritis patients with hyperuricemia.
    Petsch C; Araujo EG; Englbrecht M; Bayat S; Cavallaro A; Hueber AJ; Lell M; Schett G; Manger B; Rech J
    Semin Arthritis Rheum; 2016 Jun; 45(6):663-8. PubMed ID: 26743072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of change in urate deposition by dual-energy computed tomography among clinically stable patients with long-standing tophaceous gout: a prospective longitudinal study.
    Rajan A; Aati O; Kalluru R; Gamble GD; Horne A; Doyle AJ; McQueen FM; Dalbeth N
    Arthritis Res Ther; 2013 Oct; 15(5):R160. PubMed ID: 24286500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of musculoskeletal ultrasound in predicting gout flares in index joints: A prospective cohort study of people with gout starting urate-lowering therapy.
    Han L; Li R; Dalbeth N; Liu M; Yu Q; Jiang C; Ning C; Liu Z; He Y; Li M; Xue X; Jia F; Jia Z; Sun W; Zhang H; Lu J; Wang C; Li C
    Semin Arthritis Rheum; 2024 Aug; 67():152418. PubMed ID: 38422901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the sensitivity to change of the OMERACT ultrasound structural gout lesions during urate-lowering therapy.
    Christiansen SN; Østergaard M; Slot O; Keen H; Bruyn GAW; D'Agostino MA; Terslev L
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 32396518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, double-blind, placebo-controlled trial.
    Dalbeth N; Aati O; Gamble GD; Horne A; House ME; Roger M; Doyle AJ; Chhana A; McQueen FM; Reid IR
    Ann Rheum Dis; 2014 Jun; 73(6):1044-51. PubMed ID: 24442886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20).
    Aati O; Taylor WJ; Siegert RJ; Horne A; House ME; Tan P; Drake J; Stamp LK; Dalbeth N
    Ann Rheum Dis; 2015 Dec; 74(12):2144-50. PubMed ID: 25114061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with bone erosion in patients with gout: A dual-energy gemstone spectral imaging computed tomography study.
    Liu X; Li B; Zhang X; Mo S; Liang D; Zhu J
    Mod Rheumatol; 2022 Oct; 32(6):1170-1174. PubMed ID: 34918119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monosodium urate monohydrate crystals inhibit osteoblast viability and function: implications for development of bone erosion in gout.
    Chhana A; Callon KE; Pool B; Naot D; Watson M; Gamble GD; McQueen FM; Cornish J; Dalbeth N
    Ann Rheum Dis; 2011 Sep; 70(9):1684-91. PubMed ID: 21622970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.